P/E ratio for Conformis (CFMS)
P/E ratio as of April 2024 (TTM): -0.4046
According to Conformis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.404635. At the end of 2022 the company had a P/E ratio of -0.4812.
P/E ratio history for Conformis from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.4812 | -97.47% |
| 2021 | -19.0 | 880.08% |
| 2020 | -1.94 | -43.06% |
| 2019 | -3.41 | 604.67% |
| 2018 | -0.4838 | -74.79% |
| 2017 | -1.92 | -67.06% |
| 2016 | -5.83 | -50.68% |
| 2015 | -11.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Masimo MASI | 61.8 | -15,384.27% | 🇺🇸 USA |
 DexCom DXCM | 127 | -31,488.78% | 🇺🇸 USA |
 Avinger AVGR | -0.1133 | -72.00% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.